Patents Examined by Michael B Pallay
  • Methods and compositions for use with gel dispensers
    Patent number: 10130093
    Abstract: A dispensable gel composition is provided. The dispensable gel composition includes a C1-4 alcohol, a polyacrylate thickener, a diol plug-preventing additive, and one or more neutralizers. The one or more neutralizers are selected from sodium hydroxide, ammonium hydroxide, potassium hydroxide, arginine, tetrahydroxypropyl ethylenediamine, triethanolamine, tromethamine, and triisopropanolamine.
    Type: Grant
    Filed: May 22, 2018
    Date of Patent: November 20, 2018
    Assignee: GOJO Industries, Inc.
    Inventors: David R. Macinga, Sarah L. Edmonds, Kristin E. Hartzell, Kelly A. Dobos, Carol A. Quezada
  • Powder composition for treating a disorder in the auditory canal of mammals and use thereof
    Patent number: 10130583
    Abstract: The invention relates to a new powder composition which comprises in admixture: lactic acid, lactose and kaolin, wherein the amount of lactic acid is such that the pH of the powder composition should be within the range of about 3 to 4. Said powder composition may be use as a veterinary drug and in treating and/or preventing a disorder in the auditory canal of dogs and cats.
    Type: Grant
    Filed: April 14, 2014
    Date of Patent: November 20, 2018
    Assignee: Pegion Operations Limited
    Inventor: Claes Thulin
  • Encapsulation of hydrophobic biologically active compounds
    Patent number: 10117839
    Abstract: A composition comprising hydrophobic droplets coated by a shell and dispersed in a matrix and a consumable product comprising the composition are provided. The hydrophobic droplets comprise a hydrophobic compound, the shell comprises an irreversibly denatured protein, and the matrix comprises a protein, a starch, and a polysaccharide. Also provided are methods for preparing the composition and the consumable product.
    Type: Grant
    Filed: August 4, 2015
    Date of Patent: November 6, 2018
    Assignee: Intervet Inc.
    Inventors: Mordechai Harel, Majid Keshtmand, Swetha Kambalapally, Sara Morrison-Rowe
  • Dosage suspensions of active pharmaceutical ingredients
    Patent number: 10117859
    Abstract: Methods for preparing suspensions of active pharmaceutical ingredients for ensuing drug delivery. The suspension may include a mixture of a relatively low dosage API and a relatively high dosage API or a mixture of an API with a suitable excipient.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: November 6, 2018
    Assignee: SOUTHWEST RESEARCH INSTITUTE
    Inventors: Hong Dixon, Larry A. Cabell, Joseph A. McDonough
  • Injectable in situ polymerizable collagen composition
    Patent number: 10111981
    Abstract: The present invention is directed to injectable acid soluble collagen compositions comprising a neutralized solution of an acid soluble collagen, EDTA and preferably a polyol, wherein the composition is injectable at physiological pH and the acid soluble collagen polymerizes upon exposure to tissue. The invention is suitable for use in soft tissue augmentation, promoting soft tissue regeneration and coating medical implants and devices.
    Type: Grant
    Filed: March 4, 2014
    Date of Patent: October 30, 2018
    Assignee: DERMELLE, LLC
    Inventors: Dale P. Devore, Robert J. Brooks, Todd Byrne
  • Pest control films and methods for making same
    Patent number: 10104885
    Abstract: Pest control compositions and methods for forming a pest control composition, comprising the steps of providing a lower polymer weave; providing an upper polymer film; and mixing a pest control agent with a polymer and extruding the resulting mixture between the lower polymer weave and the upper polymer film are discussed. In addition, methods of forming a pest control composition comprising providing a lower polymer weave layer and mixing a pest control agent with a polymer and extruding the resulting mixture on the lower polymer weave layer and pest control compositions formed by such processes are discussed. Also described are pellets and monolayer films of pest control agent and polymer.
    Type: Grant
    Filed: July 31, 2013
    Date of Patent: October 23, 2018
    Assignee: PROVISIONGARD HOLDINGS, LLC
    Inventor: James Bagwell
  • Compositions, kits and methods for maintaining eyelid hygiene
    Patent number: 10085929
    Abstract: A method for treating an ocular condition involves cleansing an eyelid with a first ophthalmic composition, wherein the first ophthalmic composition consists essentially of water, PEG-80 sorbitan laurate, methyl gluceth-20, PEG-120 methyl glucose dioleate, salicyloyl phytosphingosine, decyl glucoside, 1,2 hexanediol, caprylyl glycol, disodium cocoamphodiacetate, panthenol, polyaminopropyl biguanide, sodium chloride, potassium chloride and calcium chloride followed by applying a therapeutically effective amount of a second ophthalmic composition to a margin of the eyelid, wherein the second ophthalmic composition consists essentially of water and hypochlorous acid.
    Type: Grant
    Filed: November 20, 2017
    Date of Patent: October 2, 2018
    Assignee: OCuSOFT, Inc.
    Inventors: Nat Adkins, Jr., Cynthia Barratt
  • Compositions, kits and methods for maintaining eyelid hygiene
    Patent number: 10085930
    Abstract: An ophthalmic composition comprising: (a) a mixture of antimicrobial agents that substantially eliminates at least seven bacterial strains, wherein the mixture includes polyaminopropyl biguanide, a 1,2-glycol, and a sphingoid lipid; (b) a blended surfactant solution that maintains the first ophthalmic composition at a pH between 5.5 and 7.5, wherein the blended surfactant solution has a foaming ability; (c) a foam stabilizer; and (d) a moisturizer.
    Type: Grant
    Filed: December 4, 2017
    Date of Patent: October 2, 2018
    Assignee: OCuSOFT, Inc.
    Inventors: Nat Adkins, Jr., Cynthia Barratt
  • Use of decellularized extracellular matrix for encapsulating cells
    Patent number: 10085946
    Abstract: A microparticle for cell encapsulation is provided, having a core which comprises continuous fibers of decellularized extracellular matrix (ECM) and, optionally, an outer layer. Also provided are methods of encapsulating cells in the microparticle, pharmaceutical compositions comprising the microparticle, and methods of treating disease in animals employing the microparticles of the invention, for example, treating Diabetes.
    Type: Grant
    Filed: September 3, 2013
    Date of Patent: October 2, 2018
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Marcelle Machluf, Deborah Chaimov
  • Floating gastric retentive dosage form
    Patent number: 10076500
    Abstract: An elongate dosage form of generally cylindrical shape having two opposing ends, the dosage form being buoyant in gastric fluid, wherein the dosage form is weight biased such that one end is heavier than the other end. The dosage form is adapted to float on gastric fluid with its long axis substantially perpendicular to the surface of the fluid with its heavier end pointing generally downwards and into the fluid.
    Type: Grant
    Filed: March 17, 2016
    Date of Patent: September 18, 2018
    Assignee: Jagotec AG
    Inventors: Pascal Grenier, Alain Nhamias, Guy Vergnault
  • Bone regeneration material
    Patent number: 10064979
    Abstract: A method for producing a bone regeneration material containing an octacalcium phosphate-gelatin complex, the method including: co-precipitating octacalcium phosphate with gelatin to produce an octacalcium phosphate-gelatin co-precipitate; washing the co-precipitate with a washing liquid to remove gelatin from the co-precipitate, thereby obtaining an octacalcium phosphate slurry; dispersing the octacalcium phosphate slurry or dry granules formed using the slurry in an aqueous gelatin solution; and drying the dispersion of octacalcium phosphate dispersed in the aqueous gelatin solution to produce an octacalcium phosphate-gelatin complex.
    Type: Grant
    Filed: December 1, 2014
    Date of Patent: September 4, 2018
    Assignee: TOHOKU UNIVERSITY
    Inventors: Osamu Suzuki, Keiichi Sasaki, Takahisa Anada, Risa Ishiko-Uzuka
  • Compositions and methods for treatment of short telomere disorders
    Patent number: 10046007
    Abstract: The invention generally relates to methods of treating short telomere disorders using known compounds and pharmaceutical compositions comprising same. More specifically, the disclosed methods comprise, in one aspect, the step of administering to the subject an effective amount of at least one lithium compound or a pharmaceutically acceptable salt thereof, thereby treating the subject for the short telomere disorder. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Grant
    Filed: June 24, 2016
    Date of Patent: August 14, 2018
    Assignee: Prescient Pharma, LLC
    Inventors: Pavel Idelevich, Yanming Wang
  • C-Met modulator pharmaceutical compositions
    Patent number: 10039757
    Abstract: Pharmaceutical compositions and unit dosage forms comprising Compound I are disclosed.
    Type: Grant
    Filed: February 7, 2017
    Date of Patent: August 7, 2018
    Assignee: Exelixis, Inc.
    Inventors: Jo Ann Wilson, Khalid Shah
  • C-met modulator pharmaceutical compositions
    Patent number: 10034873
    Abstract: Pharmaceutical compositions and unit dosage forms comprising Compound I are disclosed.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: July 31, 2018
    Assignee: Exelixis, Inc.
    Inventors: Jo Ann Wilson, Khalid Shah
  • Compacted hemostatic cellulosic aggregates
    Patent number: 10034957
    Abstract: The present invention is directed to a hemostatic material comprising a compacted, hemostatic aggregates of cellulosic fibers. In some aspects, the hemostatic material further includes additives, such as carboxymethyl cellulose (CMC) or other polysaccharides, calcium salts, anti-infective agents, hemostasis promoting agents, gelatin, collagen, or combinations thereof. In another aspect, the present invention is directed to a method of making the hemostatic materials described above by compacting a cellulosic-based material into hemostatic aggregates. In another aspect, the present invention is directed to a method of treating a wound by applying hemostatic materials described above onto and/or into the wound of a patient.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: July 31, 2018
    Assignee: Ethicon LLC
    Inventor: Yi-Lan Wang
  • Thermo-kinetic mixing for pharmaceutical applications
    Patent number: 10022385
    Abstract: Compositions and methods for making a pharmaceutical dosage form include making a pharmaceutical composition that includes one or more active pharmaceutical ingredients (API) with one or more pharmaceutically acceptable excipients by thermokinetic compounding into a composite. Compositions and methods of preprocessing a composite comprising one or more APIs with one or more excipients include thermokinetic compounding, comprising thermokinetic processing the APIs with the excipients into a composite, wherein the composite can be further processed by conventional methods known in the art, such as hot melt extrusion, melt granulation, compression molding, tablet compression, capsule filling, film-coating, or injection molding.
    Type: Grant
    Filed: May 13, 2016
    Date of Patent: July 17, 2018
    Assignees: Board of Regents, The University of Texas System, DisperSol Technologies, LLC
    Inventors: Chris Brough, James W. McGinity, Dave A. Miller, James C. Dinunzio, Robert O. Williams, III
  • Immobilised biological entities
    Patent number: 10016512
    Abstract: There is described inter alia a medical device having a surface which comprises a coating layer, said coating layer being a biocompatible composition comprising an anti-coagulant entity capable of interacting with mammalian blood to prevent coagulation or thrombus formation, which anti-coagulant entity is covalently attached to said surface through a linker comprising a thioether.
    Type: Grant
    Filed: June 6, 2013
    Date of Patent: July 10, 2018
    Assignee: Carmeda AB
    Inventor: Robert Vestberg
  • Solid pharmaceutical compositions of brown algae
    Patent number: 10016471
    Abstract: Described herein are solid pharmaceutical compositions of brown algae extracts and methods for making solid pharmaceutical compositions of brown algae extracts. In some embodiments, the brown algae extract is derived from Ecklonia cava.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: July 10, 2018
    Assignee: Phloronol, Inc.
    Inventors: Hyeon-Cheol Shin, Hyejeong Hwang
  • Pre-spray emulsions and powders containing non-polar compounds
    Patent number: 10016363
    Abstract: Provided are compositions and methods for producing water-soluble powders that contain additives such as essential fatty acids, including omega-3 fatty acids, omega-6 fatty acids, conjugated fatty acids, and other fatty acids; phytochemicals, including phytosterols; other oils; and coenzymes, including coenzyme Q10, and other oil-based additives.
    Type: Grant
    Filed: September 25, 2015
    Date of Patent: July 10, 2018
    Assignee: Virun, Inc.
    Inventor: Philip J. Bromley
  • Biocidal composition
    Patent number: 10011762
    Abstract: A biocidal composition includes glutaraldehyde, alkyl-based quaternary ammonium, benzyl-containing quaternary ammonium, and an isothiazolinone composition. The biocidal composition can further include water, alcohol, or a magnesium salt. Such a biocidal composition finds particular use in treating fracking fluids. The biocidal composition can be mixed with a treatment fluid prior to pumping the treatment fluid through a well head.
    Type: Grant
    Filed: July 5, 2016
    Date of Patent: July 3, 2018
    Assignee: HighQ Services, LLC
    Inventors: Fermin Navar, Babak Samani